Table 2.
PP3M characteristics
| PP3M | Total | |
|---|---|---|
| N = 97 | ||
| Initial PP3M dose (n [%]) | ||
| 525 mg | 28 | (28.9) |
| 350 mg | 42 | (43.3) |
| 263 mg | 16 | (16.5) |
| 175 mg | 11 | (11.3) |
| Dose change (n [%]) | ||
| None | 83 | (85.6) |
| Increase (n [%]) | 3 | (3.1) |
| Worsening symptoms | 2 | (66.7) |
| Patient request | 1 | (33.3) |
| Decrease (n [%]) | 11 | (11.3) |
| Patient request | 5 | (45.5) |
| Adverse effects | 4 | (36.4) |
| Improved condition | 1 | (9.1) |
| Unclear | 1 | (9.1) |